Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Boston Scientific Corporation(BSX) | 515,000 | 336,000 | -179,000 | $46.00M | $33.90M | 6.99% | -$12.10M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,873,000 | 1,720,902 | -1,152,098 | $62.63M | $31.22M | 6.44% | -$31.41M |
| UnitedHealth Group Incorporated(UNH) | 60,000 | 50,500 | -9,500 | $30.35M | $26.45M | 5.46% | -$3.90M |
| CG Oncology, Inc.(CGON) | 1,097,800 | 980,942 | -116,858 | $31.48M | $24.02M | 4.95% | -$7.46M |
| Humana Inc.(HUM) | 89,200 | 81,000 | -8,200 | $22.63M | $21.43M | 4.42% | -$1.20M |
| Natera, Inc.(NTRA) | 223,800 | 119,200 | -104,600 | $35.43M | $16.86M | 3.48% | -$18.57M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 8,400 | 25,400 | +17,000 | $5.98M | $16.11M | 3.32% | +$10.13M |
| Endeavour Silver Corp.(EXK) | 603,011 | 353,000 | -250,011 | $33.88M | $15.28M | 3.15% | -$18.60M |
| Beam Therapeutics Inc.(BEAM) | 0 | 709,517 | +709,517 | $0 | $13.86M | 2.86% | +$13.86M |
| Glaukos Corporation(GKOS) | 170,000 | 134,000 | -36,000 | $25.49M | $13.19M | 2.72% | -$12.30M |
| DexCom, Inc.(DXCM) | 318,000 | 180,000 | -138,000 | $24.73M | $12.29M | 2.54% | -$12.44M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 352,000 | 322,100 | -29,900 | $14.81M | $11.66M | 2.41% | -$3.15M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,500,000 | 925,000 | -575,000 | $19.83M | $11.36M | 2.34% | -$8.47M |
| Cencora Inc | 0 | 39,300 | +39,300 | $0 | $10.93M | 2.25% | +$10.93M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 234,500 | 80,000 | -154,500 | $28.88M | $9.93M | 2.05% | -$18.95M |
| Tenet Healthcare Corporation(THC) | 137,000 | 72,000 | -65,000 | $17.29M | $9.68M | 2.00% | -$7.61M |
| Neurocrine Biosciences, Inc.(NBIX) | 220,400 | 85,700 | -134,700 | $30.08M | $9.48M | 1.95% | -$20.61M |
| Danaher Corporation(DHR) | 67,000 | 44,500 | -22,500 | $15.38M | $9.12M | 1.88% | -$6.26M |
| Axsome Therapeutics, Inc.(AXSM) | 188,000 | 77,000 | -111,000 | $15.91M | $8.98M | 1.85% | -$6.93M |
| Insmed Incorporated(INSM) | 232,800 | 107,000 | -125,800 | $16.07M | $8.16M | 1.68% | -$7.91M |
| Organon & Co.(OGN) | 0 | 535,000 | +535,000 | $0 | $7.97M | 1.64% | +$7.97M |
| Thermo Fisher Scientific Inc.(TMO) | 44,600 | 15,500 | -29,100 | $23.20M | $7.71M | 1.59% | -$15.49M |
| Xenon Pharmaceuticals Inc.(XENE) | 474,000 | 229,000 | -245,000 | $18.58M | $7.68M | 1.58% | -$10.90M |
| Spdr Ser TrS P BIOTECH ST STR SP BIOT | 0 | 94,000 | +94,000 | $0 | $7.62M | 1.57% | +$7.62M |
| Centessa Pharmaceuticals PlcADS | 1,165,800 | 529,000 | -636,800 | $19.53M | $7.61M | 1.57% | -$11.92M |
| Revolution Medicines, Inc.(RVMD) | 446,200 | 213,000 | -233,200 | $19.52M | $7.53M | 1.55% | -$11.99M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 0 | 481,000 | +481,000 | $0 | $7.39M | 1.52% | +$7.39M |
| Avantor, Inc.(AVTR) | 947,000 | 453,000 | -494,000 | $19.95M | $7.34M | 1.51% | -$12.61M |
| IDEAYA Biosciences, Inc.(IDYA) | 1,126,700 | 445,000 | -681,700 | $28.96M | $7.29M | 1.50% | -$21.67M |
| Doximity, Inc.CL A(DOCS) | 0 | 122,500 | +122,500 | $0 | $7.11M | 1.47% | +$7.11M |
| Janux Therapeutics, Inc.(JANX) | 741,900 | 258,000 | -483,900 | $39.72M | $6.97M | 1.44% | -$32.76M |
| HealthEquity, Inc.(HQY) | 0 | 78,000 | +78,000 | $0 | $6.89M | 1.42% | +$6.89M |
| Blueprint Medicines Corp | 176,600 | 68,500 | -108,100 | $15.40M | $6.06M | 1.25% | -$9.34M |
| United Therapeutics Corporation(UTHR) | 0 | 16,800 | +16,800 | $0 | $5.18M | 1.07% | +$5.18M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 1,390,100 | 800,000 | -590,100 | $11.29M | $5.02M | 1.03% | -$6.27M |
| Immunic, Inc.(IMUX) | 7,966,400 | 4,454,408 | -3,511,992 | $7.97M | $4.86M | 1.00% | -$3.11M |
| Bruker Corporation(BRKR) | 76,300 | 115,000 | +38,700 | $4.47M | $4.80M | 0.99% | +$327.4K |
| Perspective Therapeutics, Inc.(CATX) | 2,694,600 | 2,197,270 | -497,330 | $8.60M | $4.68M | 0.97% | -$3.92M |
| Context Therapeutics Inc.(CNTX) | 7,477,200 | 7,477,200 | 0 | $7.85M | $4.58M | 0.94% | -$3.28M |
| Oruka Therapeutics, Inc.(ORKA) | 352,124 | 352,124 | 0 | $6.83M | $3.61M | 0.75% | -$3.21M |
| uniQure N.V.SHS(QURE) | 222,000 | 336,200 | +114,200 | $3.92M | $3.56M | 0.74% | -$356.8K |
| Biohaven Ltd.(BHVN) | 222,900 | 145,000 | -77,900 | $8.33M | $3.49M | 0.72% | -$4.84M |
| Arvinas, Inc.(ARVN) | 1,358,000 | 413,162 | -944,838 | $26.03M | $2.90M | 0.60% | -$23.13M |
| Acadia Pharmaceuticals Inc | 0 | 169,000 | +169,000 | $0 | $2.81M | 0.58% | +$2.81M |
| Royalty Pharma plcCL A(RPRX) | 0 | 87,000 | +87,000 | $0 | $2.71M | 0.56% | +$2.71M |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 75,000 | +75,000 | $0 | $2.59M | 0.53% | +$2.59M |
| Kezar Life Sciences Inc COM NEW | 502,600 | 502,600 | 0 | $3.38M | $2.45M | 0.51% | -$924.8K |
| Akero Therapeutics Inc | 82,000 | 57,000 | -25,000 | $2.28M | $2.31M | 0.48% | +$26.1K |
| Soleno Therapeutics Inc | 0 | 32,000 | +32,000 | $0 | $2.29M | 0.47% | +$2.29M |
| Capricor Therapeutics, Inc.(CAPR) | 0 | 239,000 | +239,000 | $0 | $2.27M | 0.47% | +$2.27M |
| Lexeo Therapeutics, Inc.(LXEO) | 0 | 645,000 | +645,000 | $0 | $2.24M | 0.46% | +$2.24M |
| Vera Therapeutics, Inc.CL A(VERA) | 100,000 | 91,000 | -9,000 | $4.23M | $2.19M | 0.45% | -$2.04M |
| REGENXBIO Inc.(RGNX) | 532,000 | 260,000 | -272,000 | $4.11M | $1.86M | 0.38% | -$2.25M |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 60,000 | +60,000 | $0 | $1.81M | 0.37% | +$1.81M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 666,200 | 40,000 | -626,200 | $27.55M | $1.80M | 0.37% | -$25.75M |
| Newamsterdam Pharma Company ORDINARY SHARES | 354,000 | 68,000 | -286,000 | $9.10M | $1.39M | 0.29% | -$7.71M |
| agilon health, inc.(AGL) | 0 | 305,100 | +305,100 | $0 | $1.32M | 0.27% | +$1.32M |
| SCYNEXIS, Inc.(SCYX) | 1,228,910 | 1,228,910 | 0 | $1.49M | $1.17M | 0.24% | -$316.9K |
| Vaxcyte, Inc.(PCVX) | 0 | 23,000 | +23,000 | $0 | $868.5K | 0.18% | +$868.5K |
| Karyopharm Therapeutics Inc.(KPTI) | 0 | 134,566 | +134,566 | $0 | $503.3K | 0.10% | +$503.3K |
| Enliven Therapeutics Inc | 0 | 11,300 | +11,300 | $0 | $222.4K | 0.05% | +$222.4K |
| Hyperfine, Inc.CL A(HYPR) | 1,188,178 | 222,174 | -966,004 | $1.05M | $159.1K | 0.03% | -$886.5K |
| Reviva Pharmaceutcls Hldgs I | 0 | 138,000 | +138,000 | $0 | $131.6K | 0.03% | +$131.6K |
| AbbVie Inc.(ABBV) | 80,700 | 0 | -80,700 | $14.34M | $0 | — | -$14.34M |
| Acadia Healthcare Company, Inc.(ACHC) | 658,000 | 0 | -658,000 | $26.09M | $0 | — | -$26.09M |
| Ascendis Pharma A/SADR(ASND) | 62,000 | 0 | -62,000 | $8.54M | $0 | — | -$8.54M |
| Bluebird Bio Inc | 81,555 | 0 | -81,555 | $680.2K | $0 | — | -$680.2K |
| Bristol-Myers Squibb Company(BMY) | 215,000 | 0 | -215,000 | $12.16M | $0 | — | -$12.16M |
| Cogent Biosciences, Inc.(COGT) | 287,104 | 0 | -287,104 | $2.24M | $0 | — | -$2.24M |
| Dyne Therapeutics, Inc.(DYN) | 96,000 | 0 | -96,000 | $2.26M | $0 | — | -$2.26M |
| Illumina, Inc.(ILMN) | 109,700 | 0 | -109,700 | $14.66M | $0 | — | -$14.66M |
| Incyte Corporation(INCY) | 129,600 | 0 | -129,600 | $8.95M | $0 | — | -$8.95M |
| Intra-Cellular Therapies Inc | 97,000 | 0 | -97,000 | $8.10M | $0 | — | -$8.10M |
| Intuitive Surgical, Inc.(ISRG) | 64,800 | 0 | -64,800 | $33.82M | $0 | — | -$33.82M |
| Karyopharm Therapeutics Inc.(KPTI) | 2,018,500 | 0 | -2,018,500 | $1.37M | $0 | — | -$1.37M |
| Keros Therapeutics, Inc.(KROS) | 210,000 | 0 | -210,000 | $3.32M | $0 | — | -$3.32M |
| Kymera Therapeutics, Inc.(KYMR) | 500,000 | 0 | -500,000 | $20.11M | $0 | — | -$20.11M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 1,265,200 | 0 | -1,265,200 | $10.21M | $0 | — | -$10.21M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,053,300 | 0 | -1,053,300 | $13.24M | $0 | — | -$13.24M |
| Surgery Partners, Inc.(SGRY) | 514,200 | 0 | -514,200 | $10.89M | $0 | — | -$10.89M |
| TransMedics Group, Inc.(TMDX) | 192,400 | 0 | -192,400 | $12.00M | $0 | — | -$12.00M |